We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Charles River Laboratories International Inc | NYSE:CRL | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
3.58 | 1.56% | 233.47 | 238.38 | 232.18 | 233.61 | 466,193 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
FOSTER JAMES C |
2. Issuer Name
and
Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC [ CRL ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chairman, President and CEO |
251 BALLARDVALE STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
WILMINGTON, MA 01887 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.185 | 342298 | D | |||
Common Stock | 7/10/2017 | S (1) | 200 | D | $99.19 | 342098 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.195 | 341998 | D | |||
Common Stock | 7/10/2017 | S (1) | 200 | D | $99.20 | 341798 | D | |||
Common Stock | 7/10/2017 | S (1) | 5 | D | $99.205 | 341793 | D | |||
Common Stock | 7/10/2017 | S (1) | 912 | D | $99.21 | 340881 | D | |||
Common Stock | 7/10/2017 | S (1) | 1 | D | $99.215 | 340880 | D | |||
Common Stock | 7/10/2017 | S (1) | 613 | D | $99.22 | 340267 | D | |||
Common Stock | 7/10/2017 | S (1) | 200 | D | $99.23 | 340067 | D | |||
Common Stock | 7/10/2017 | S (1) | 200 | D | $99.25 | 339867 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.255 | 339767 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.26 | 339667 | D | |||
Common Stock | 7/10/2017 | S (1) | 300 | D | $99.27 | 339367 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.28 | 339267 | D | |||
Common Stock | 7/10/2017 | S (1) | 99 | D | $99.29 | 339168 | D | |||
Common Stock | 7/10/2017 | S (1) | 249 | D | $99.30 | 338919 | D | |||
Common Stock | 7/10/2017 | S (1) | 40 | D | $99.315 | 338879 | D | |||
Common Stock | 7/10/2017 | S (1) | 700 | D | $99.32 | 338179 | D | |||
Common Stock | 7/10/2017 | S (1) | 101 | D | $99.33 | 338078 | D | |||
Common Stock | 7/10/2017 | S (1) | 300 | D | $99.37 | 337778 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.395 | 337678 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.40 | 337578 | D | |||
Common Stock | 7/10/2017 | S (1) | 300 | D | $99.41 | 337278 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.42 | 337178 | D | |||
Common Stock | 7/10/2017 | S (1) | 100 | D | $99.54 | 337078 | D | |||
Common Stock | 7/10/2017 | S (1) | 400 | D | $99.62 | 336678 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: | |
(1) | This sale occurred pursuant to a 10b5-1 Trading Plan. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
FOSTER JAMES C
251 BALLARDVALE STREET WILMINGTON, MA 01887 |
X |
|
Chairman, President and CEO |
|
Signatures
|
||
/s/ James C. Foster | 7/10/2017 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Charles River Laboratories Chart |
1 Month Charles River Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions